HAI-2 was initially identified and purified from the conditioned medium of MNK 45 human gastric cancer cells based on its ability to inhibit the serine protease hepatocyte growth factor activator (HGFA) from which it received its name [1]. The gene discussed is HGFAC; the disease is gastric cancer.